» Articles » PMID: 3232991

Two Minute Walking Distance in Cystic Fibrosis

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 1988 Dec 1
PMID 3232991
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We have evaluated the 'two minute walking distance' in children with cystic fibrosis as an objective measurement of exercise tolerance. There was a strong correlation between walking distance and height in 89 normal children (r = 0.72). Fifty children with cystic fibrosis showed a similar correlation (r = 0.56) with a mean result of 94% of that expected for height compared with the normal children. There was a training effect in the normal children with the second walk being significantly better than the first, but this was not evident in children with cystic fibrosis. The test was reproducible with no significant change in 12 children retested after one to three months. Sixteen children with cystic fibrosis admitted for treatment of chest disease showed a significant improvement in walking distance with treatment. Children as young as 5 years old can perform a walking distance test. It seems to be an objective way of assessing exercise tolerance and can help in evaluating response to treatment.

Citing Articles

Two-minute versus 6-minute walk distances during 6-minute walk test in neuromuscular disease: Is the 2-minute walk test an effective alternative to a 6-minute walk test?.

Witherspoon J, Vasavada R, Logaraj R, Waite M, Collins J, Shieh C Eur J Paediatr Neurol. 2018; 23(1):165-170.

PMID: 30449663 PMC: 6423958. DOI: 10.1016/j.ejpn.2018.10.001.


Home IV Antibiotic Therapy and Exercise Capacity in Children with CF: A Case Series.

Cox N, McKay K, Follett J, Alison J Cardiopulm Phys Ther J. 2011; 22(1):16-9.

PMID: 21448344 PMC: 3056840.


Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.

Mok E, Letellier G, Cuisset J, Denjean A, Gottrand F, Alberti C PLoS One. 2009; 4(5):e5448.

PMID: 19421321 PMC: 2673684. DOI: 10.1371/journal.pone.0005448.


Exercise recommendations for individuals with cystic fibrosis.

Boas S Sports Med. 1997; 24(1):17-37.

PMID: 9257408 DOI: 10.2165/00007256-199724010-00003.


Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.

Morris K, Sharp J, Watson S, Coulthard M Arch Dis Child. 1993; 69(5):580-6.

PMID: 8257180 PMC: 1029623. DOI: 10.1136/adc.69.5.580.

References
1.
Day G, MEARNS M . Bronchial lability in cystic fibrosis. Arch Dis Child. 1973; 48(5):355-9. PMC: 1648390. DOI: 10.1136/adc.48.5.355. View

2.
McGavin C, Gupta S, McHARDY G . Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J. 1976; 1(6013):822-3. PMC: 1639415. DOI: 10.1136/bmj.1.6013.822. View

3.
Mungall I, Hainsworth R . Assessment of respiratory function in patients with chronic obstructive airways disease. Thorax. 1979; 34(2):254-8. PMC: 471049. DOI: 10.1136/thx.34.2.254. View

4.
Butland R, Pang J, Gross E, Woodcock A, Geddes D . Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed). 1982; 284(6329):1607-8. PMC: 1498516. DOI: 10.1136/bmj.284.6329.1607. View

5.
Redding G, Restuccia R, COTTON E, Brooks J . Serial changes in pulmonary functions in children hospitalized with cystic fibrosis. Am Rev Respir Dis. 1982; 126(1):31-6. DOI: 10.1164/arrd.1982.126.1.31. View